SunOpta Insider Keating Boosts Stake to 130.9k Shares
Rhea-AI Filing Summary
SunOpta Inc. (STKL) – Form 4 insider filing dated 07/29/2025
- Reporting person: Director Leslie Starr Keating
- Transaction date: 07/25/2025
- Common shares acquired: 3,683 shares, issued in lieu of cash director fees, at an accounting price of $6.64 per share (Code A).
- Restricted Stock Units (RSUs): 2,423 RSUs granted; each RSU converts 1-for-1 into common stock, no exercise price or expiration.
- Post-transaction ownership: 130,856 common shares (direct) and 39,740 RSUs (direct).
No dispositions were reported and the filing was made by a single reporting person. The equity was awarded as compensation rather than an open-market purchase, but it nonetheless increases the director’s direct economic alignment with shareholders.
Positive
- Director’s equity stake increases, raising alignment with shareholders to 130,856 common shares plus 39,740 RSUs.
- No shares were sold; only acquisitions reported, avoiding negative sentiment from insider selling.
Negative
- None.
Insights
TL;DR – Director received stock/RSUs as board pay, lifting ownership to 130.9k shares; modestly positive alignment signal.
The grant consists of routine, board-fee equity rather than discretionary buying, yet it adds to the director’s stake and leaves no selling pressure. At ~3.7k shares plus 2.4k RSUs, the dollar value is minor relative to SunOpta’s market cap but still enhances insider alignment. No negative governance flags appear; Form 4 filed timely and reflects straight-forward compensation mechanics.
TL;DR – Incremental insider accumulation, but size immaterial; neutral-to-slightly-positive signal.
While insider “buy” code A often cheers investors, context shows these shares were automatic fee conversions, not cash-outlay purchases—limiting signaling value. Still, total holdings over 170k share equivalents suggest meaningful skin-in-the-game for this director. Absent broader buying trends or open-market purchases, market impact should be limited.
FAQ
How many SunOpta (STKL) shares did Director Leslie Starr Keating acquire?
What was the price of the STKL shares issued to the director?
Were any SunOpta shares sold in this Form 4 filing?
How many Restricted Stock Units were granted?
What is the director’s total STKL ownership after the transaction?
Do the RSUs have an expiration date?